Opicapone Effect on Sleep Disorders in Fluctuating Parkinson’s Disease Patients: Findings from the OASIS Trial

Ongentys (opicapone) - Ono Pharma, Neurocrine, BIAL

J. Ferreira 1; M. Gago 2; R. Costa 3; M. Fonseca 3; J. Almeida 3; J. Rocha 3; J. Holenz 3; C. Trenkwalder 4

Jul 2, 2024